PIA
AMED

Piedmont Investment Advisors’s Amedisys AMED Stock Holding History

Piedmont Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,953
Closed -$542K – 37
2020
Q1 		$542K Buy
2,953
+6
+0.2% +$1.07K 0.02% 422
2019
Q4 		$492K Sell
2,947
-453
-13% -$67.4K 0.02% 517
2019
Q3 		$445K Sell
3,400
-394
-10% -$51.3K 0.02% 570
2019
Q2 		$461K Buy
+3,794
New +$450K 0.02% 578
2019
Q1 		– Sell
-6,865
Closed -$804K – 1159
2018
Q4 		$804K Buy
6,865
+230
+3% +$27.1K 0.04% 312
2018
Q3 		$829K Sell
6,635
-33
-0.5% -$3.64K 0.03% 348
2018
Q2 		$570K Buy
6,668
+567
+9% +$41.6K 0.03% 406
2018
Q1 		$368K Buy
6,101
+241
+4% +$13.7K 0.01% 496
2017
Q4 		$309K Sell
5,860
-17,562
-75% -$926K 0.01% 561
2017
Q3 		$1.31M Buy
23,422
+17,368
+287% +$918K 0.03% 279
2017
Q2 		$380K Buy
+6,054
New +$353K 0.01% 488

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Piedmont Investment Advisors's AMED Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Amedisys (AMED) in Q2 2020, closing a stake of 2,953 shares — an estimated $542K sold.

Piedmont Investment Advisors first reported a position in AMED in Q2 2017 and held it in 11 quarters. The position peaked at $1.31M in Q3 2017. 355 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 2,953 Amedisys shares in Q2 2020, an estimated $542K.
  • Piedmont Investment Advisors first reported a position in Amedisys in Q2 2017 and held it in 11 quarters.
  • Piedmont Investment Advisors's Amedisys position peaked at $1.31M in Q3 2017.
  • 355 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.